IDEAYA Biosciences, Inc. (IDYA) — Analyst outlook / Analyst consensus target is. Based on 24 analyst ratings, the consensus is bullish — 22 Buy, 2 Hold.
The consensus price target is $46.75 (low: $30.00, high: $60.00), representing an upside of 44.5% from the current price $32.35.
Analysts estimate Earnings Per Share (EPS) of $-2.47 and revenue of $0.01B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-3.36 vs est $-2.47 (missed -36.2%). 2025: actual $-1.28 vs est $-1.29 (beat +0.5%). Analyst accuracy: 86%.
IDYA Stock — 12-Month Price Forecast
$46.75
▲ +44.51% Upside
Average Price Target
Based on 24 Wall Street analysts offering 12-month price targets for IDEAYA Biosciences, Inc., the average price target is $46.75, with a high forecast of $60.00, and a low forecast of $30.00.
The average price target represents a +44.51% change from the last price of $32.35.
Highest Price Target
$60.00
Average Price Target
$46.75
Lowest Price Target
$30.00
IDYA Analyst Ratings
Buy
Based on 24 analysts giving stock ratings to IDEAYA Biosciences, Inc. in the past 3 months
EPS Estimates — IDYA
86%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$3.36
vs Est –$2.47
▼ 26.6% off
2025
Actual –$1.28
vs Est –$1.29
▲ 0.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — IDYA
83%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.007B
vs Est $0.005B
▲ 33.3% off
2025
Actual $0.219B
vs Est $0.217B
▲ 0.8% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
